Meyer Handelman Co. Has $821,000 Position in Solventum Co. (NYSE:SOLV)

Meyer Handelman Co. cut its stake in Solventum Co. (NYSE:SOLV) by 46.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,422 shares of the company’s stock after selling 10,662 shares during the quarter. Meyer Handelman Co.’s holdings in Solventum were worth $821,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of SOLV. Hollencrest Capital Management bought a new stake in Solventum in the second quarter valued at approximately $25,000. Modus Advisors LLC bought a new position in shares of Solventum during the fourth quarter worth $25,000. Copeland Capital Management LLC acquired a new position in shares of Solventum in the 3rd quarter valued at $26,000. Mather Group LLC. bought a new stake in shares of Solventum in the 3rd quarter valued at $27,000. Finally, Twin Lakes Capital Management LLC acquired a new stake in Solventum during the 2nd quarter worth $29,000.

Analyst Ratings Changes

A number of research analysts have issued reports on SOLV shares. Mizuho assumed coverage on Solventum in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 target price for the company. Piper Sandler lifted their price objective on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. Morgan Stanley increased their target price on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. Wolfe Research began coverage on shares of Solventum in a report on Thursday, September 26th. They issued a “peer perform” rating for the company. Finally, Stifel Nicolaus started coverage on shares of Solventum in a report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective on the stock. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Trading Up 2.5 %

NYSE:SOLV opened at $70.25 on Wednesday. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The stock’s 50-day simple moving average is $69.18 and its 200 day simple moving average is $65.24.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.